A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761(®) in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.
- DOI
- 10.3389/fnhum.2026.1658342
- Published
- 2026
- Container
- Frontiers in human neuroscience
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fnhum.2026.1658342,
title = {A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761(®) in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.},
author = {Matias-Guiu JA and Arelin K and Serrano PJ and Wacker A and Sória MG and Burkart M and Zifko U},
year = {2026},
journal = {Frontiers in human neuroscience},
doi = {10.3389/fnhum.2026.1658342},
url = {https://doi.org/10.3389/fnhum.2026.1658342}
}RIS
TY - JOUR TI - A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761(®) in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol. AU - Matias-Guiu JA AU - Arelin K AU - Serrano PJ AU - Wacker A AU - Sória MG AU - Burkart M AU - Zifko U PY - 2026 JO - Frontiers in human neuroscience DO - 10.3389/fnhum.2026.1658342 UR - https://doi.org/10.3389/fnhum.2026.1658342 ER -
APA
JA, M., K, A., PJ, S., A, W., MG, S., M, B., & U, Z. (2026). A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761(®) in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.. Frontiers in human neuroscience. https://doi.org/10.3389/fnhum.2026.1658342
Source records
- pubmed · retrieved 2026-09-25T17:04:01.395Z